Amgen Inc (AMGN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account
Sell

$270.73

Buy

$271.00

arrow-down$-3.93 (-1.43%)

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
Prices updated at 13 May 2025, 16:34 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Most recent dividend payment

2.380
Cash Dividend
16 May 2025
04 Mar 2025
16 May 2025
06 Jun 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202502.557.510

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20254.7600-
20249.00000.06
20238.52000.10
20227.76000.10
20217.04000.10
20206.40000.10
20195.80000.10
20185.28000.15
20174.60000.15
20164.00000.27

Total dividend yield data table

YearDividend yield (%)Buyback yield (%)Total yield (%)
20253.140.133.27
20243.45-3.45
20232.96-2.96
20222.955.578.52
20213.133.776.90
20202.782.545.32
20192.416.128.53
20182.7113.4316.14
20172.652.665.31
20162.741.994.73

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202502.557.510

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)20212022202320242025050100150

Dividend per share data table

YearDividend per share
20254.7600
20249.0000
20238.5200
20227.7600
20217.0400
20206.4000
20195.8000
20185.2800
20174.6000
20164.0000

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025119.05
2024113.41
202359.25
202260.83
202170.93
202050.36
201943.55
2018133.07
201740.20
201637.94
Latest Financial Report as of 12 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.